{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-044243","form_type":"8-K","ticker":"LSH","cik":"0001996192","company_name":"Lakeside Holding Ltd","filed_at":"2025-05-15T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.655534+00:00","generated_at":"2026-05-21T06:03:54.785170+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Lakeside Q3 FY2025 revenue falls 15% to $3.8M; net loss of $1.07M vs prior profit","bullets":["Total revenue $3.80M, down from $4.46M YoY; cross-border freight fell 26%, pharma distribution added $0.50M.","Net loss attributable to Lakeside $1.07M ($0.14 per share) vs net income $0.01M in Q3 FY2024.","Nine-month net loss $4.35M ($0.58 per share) vs $0.23M loss a year ago; operating expenses rose to $5.60M from $2.90M.","Hupan Pharma acquisition closed Nov 2024; contributed $715K to nine-month revenue. Convertible debt up to $4.5M secured March 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-044243","json":"https://secwatch.observer/filing/0001213900-25-044243.json","markdown":"https://secwatch.observer/filing/0001213900-25-044243.md","text":"https://secwatch.observer/filing/0001213900-25-044243.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1996192/000121390025044243/0001213900-25-044243-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1996192/000121390025044243/ea0242416-8k_lakeside.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-21T06:03:54.785170+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}